(GANX)
Gain Therapeutics share price is $1.59 & ₹135.46 as on 25 Dec 2024, 2.30 'hrs' IST
$1.59
▲
0.02
(1.27%)
Market is closed - opens 8 PM, 26 Dec 2024
View live Gain Therapeutics share price in Dollar and Rupees. Guide to invest in Gain Therapeutics from India. Also see the sentimental analysis on Indian investors investing in Gain Therapeutics. Get details on the Indian mutual funds that are investing in Gain Therapeutics. Get Analyst recommendations and forecasts along with all the Gain Therapeutics's financials.
2.83%
Downside
Day's Volatility :4.04%
Upside
1.24%
44.03%
Downside
52 Weeks Volatility :83.3%
Upside
70.17%
in dollars & INR
It is very easy for Indian residents to invest directly in Gain Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Gain Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Gain Therapeutics or GANX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Gain Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.
For example: You can easily buy Rs.100 worth of Gain Therapeutics shares which would translate to 0.536 fractional shares of Gain Therapeutics as of today. Learn more about fractional investing.
Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Gain Therapeutics, in just a few clicks!
Investment Value
₹1,00,000
Gain Therapeutics investment value today
Current value as on today
₹59,639
Returns
Returns from Gain Therapeutics Stock
Dollar Returns
₹2,239 (+2.24%)
Gotham Asset Management, LLC
1.26%
Geode Capital Management, LLC
1.03%
Vanguard Group Inc
0.55%
BlackRock Inc
0.32%
JONES FINANCIAL COMPANIES LLLP
0.20%
Renaissance Technologies Corp
0.20%
Buy
90%Buy
9%Hold
0%Sell
Based on 11 Wall street analysts offering stock ratings for Gain Therapeutics(by analysts ranked 0 to 5 stars)
What analysts predicted
Upside of 361.21%
Current:
$1.59
Target:
$7.33
Sell
Neutral
Buy
Gain Therapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Gain Therapeutics share price today stands at $1.59, Open: $1.59 ; Previous Close: $1.57 ; High: $1.61 ; Low: $1.55 ; 52 Week High: $5.33 ; 52 Week Low: $0.89. The stock opens at $1.59, after a previous close of $1.57. The stock reached a daily high of $1.61 and a low of $1.55, with a 52-week high of $5.33 and a 52-week low of $0.89.
Yes, Indians can invest in the Gain Therapeutics (GANX) from India.
With INDmoney, you can buy Gain Therapeutics at 0 brokerage. The step-by-step process is as follows:
It is very easy to buy Gain Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.
Yes, you can buy fractional shares of Gain Therapeutics with INDmoney app.
To start investing in Gain Therapeutics, You will need the following documents:
These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.
Today’s highest price of Gain Therapeutics (GANX) is $1.61.
Today’s lowest price of Gain Therapeutics (GANX) is $1.55.
52 Week High
$5.33
52 Week Low
$0.89
1 Month Returns
-8.09%
3 Months Returns
27.2%
1 Year Returns
-42.6%
5 Years Returns
-85.8%
Bionomics Ltd
$0.25
+0.0%
First Community Corp (south Carolina)
$24.46
+1.62%
Invesco Msci Eafe Income Advantage Etf
$46.86
+0.38%
Cosmos Health Inc
$0.66
+6.75%
New England Realty Associates Lp
$80.59
+0.0%
Contextlogic Inc.
$6.68
+1.21%
Bicycle Therapeutics Plc
$14.69
+1.03%
Global X Nasdaq 100 Risk Man
$17.69
+0.23%
First Trust Indxx Aerospace & Defense Etf
$30.94
+0.88%